Transaction in Own Shares
Summary by AI BETAClose X
BP p.l.c.
Transaction in Own Shares
BP p.l.c. (the "Company") announces that on 3 February 2026 it has purchased, in accordance with the authority granted by shareholders at the 2025 Annual General Meeting of the Company, a total of 2,836,583 of its ordinary shares of $0.25 each ("Shares") on the London Stock Exchange and Cboe (UK) as part of the buyback programme announced on 4 November 2025 (the "Programme") and as detailed below:
|
|
London Stock Exchange |
Cboe (UK)/BXE |
Cboe (UK)/CXE |
|
Number of Shares purchased: |
2,106,698 |
107,359 |
622,526 |
|
Highest price paid per Share (pence): |
465.85 |
465.80 |
465.85 |
|
Lowest price paid per Share (pence): |
456.00 |
456.50 |
456.25 |
|
Volume weighted average price paid per Share (pence): |
460.8986 |
460.6250 |
460.7275 |
The Company intends to transfer the Shares into treasury in accordance with the authority granted by its shareholders at the Company's 2025 Annual General Meeting.
Following the above purchase of Shares, the Company will hold 777,987,541 ordinary shares in treasury and have 15,708,325,453 ordinary shares and 12,706,252 preference shares in issue (excluding Treasury shares).
The schedule below contains detailed information about the purchases made by Morgan Stanley and Co. International p.l.c. (intermediary code: MSLNGB2X) on the date of purchase as part of the Programme.
Further enquiries:
bp Investor Relations +44(0) 207 496 4000
Schedule of Purchases
Shares purchased: BP p.l.c. (ISIN CODE: GB0007980591)
Aggregate information:
|
Venue |
Volume-weighted average price (pence) |
Aggregated volume |
|
London Stock Exchange |
460.8986 |
2,106,698 |
|
Cboe (UK)/BXE |
460.6250 |
107,359 |
|
Cboe (UK)/CXE |
460.7275 |
622,526 |
Individual transactions:
To view details of the individual transactions, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/5845R_1-2026-2-3.pdf
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 11 hours ago Johnson Matthey
- 12 hours ago Galliford Try
- 12 hours ago Galliford Try
- 12 hours ago Centrica
- 13 hours ago Smith & Nephew